• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿尔茨海默病治疗的胆碱能和谷氨酸能药物。

Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.

作者信息

Clarke Nicholas A, Francis Paul T

机构信息

West Kent NHS and Social Care Trust, King's Hill, Kent, UK.

出版信息

Expert Rev Neurother. 2005 Sep;5(5):671-82. doi: 10.1586/14737175.5.5.671.

DOI:10.1586/14737175.5.5.671
PMID:16162091
Abstract

The pathology and clinical symptoms of Alzheimer's disease are well known and include plaques, tangles, cell loss and dysfunction. The target of current treatments is to improve neuronal dysfunction and produce symptomatic benefits based on a clear understanding of neurotransmitter biochemistry. The purpose of this review is to examine the scientific background to currently available treatments, discuss the clinical experience of employing these drugs in Alzheimer's disease patients and review the socioeconomic influences on their use in the future.

摘要

阿尔茨海默病的病理学和临床症状已为人熟知,包括斑块、缠结、细胞丢失和功能障碍。当前治疗的目标是在清楚了解神经递质生物化学的基础上改善神经元功能障碍并产生症状缓解效果。本综述的目的是审视现有治疗方法的科学背景,讨论在阿尔茨海默病患者中使用这些药物的临床经验,并回顾未来其使用的社会经济影响。

相似文献

1
Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.用于阿尔茨海默病治疗的胆碱能和谷氨酸能药物。
Expert Rev Neurother. 2005 Sep;5(5):671-82. doi: 10.1586/14737175.5.5.671.
2
Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.阿尔茨海默病的治疗:从药理学到对疾病病理生理学的深入理解
Mech Ageing Dev. 2006 Feb;127(2):148-57. doi: 10.1016/j.mad.2005.09.018. Epub 2005 Nov 8.
3
Cholinergic therapies for Alzheimer's disease: progress and prospects.用于治疗阿尔茨海默病的胆碱能疗法:进展与前景
Curr Opin Investig Drugs. 2003 Jul;4(7):820-5.
4
Alzheimer's disease: cognitive and behavioral pharmacotherapy.阿尔茨海默病:认知与行为的药物治疗
Conn Med. 1997 Sep;61(9):543-52.
5
[Alzheimer's disease: from brain lesions to new drugs].[阿尔茨海默病:从脑部病变到新药]
Bull Acad Natl Med. 2008 Feb;192(2):363-78; discussion 378-80.
6
The cholinergic deficit in Alzheimer's disease.阿尔茨海默病中的胆碱能缺陷。
J Clin Psychiatry. 1998;59 Suppl 13:19-22.
7
[Current and future medical treatment of Alzheimer's disease].[阿尔茨海默病的当前及未来医学治疗]
Rev Med Brux. 2005 Sep;26(4):S294-9.
8
Neuropathologic changes in Alzheimer's disease: potential targets for treatment.阿尔茨海默病的神经病理变化:治疗的潜在靶点。
J Clin Psychiatry. 2006;67 Suppl 3:3-7; quiz 23.
9
[Cholinomimetic drugs for Alzheimer's disease?].用于治疗阿尔茨海默病的拟胆碱药物?
Neurologia. 1995 May;10(5):187-8.
10
Rethinking Alzheimer's disease therapy: are mitochondria the key?重新思考阿尔茨海默病的治疗方法:线粒体是关键吗?
J Alzheimers Dis. 2010;20 Suppl 2:S579-90. doi: 10.3233/JAD-2010-100327.

引用本文的文献

1
Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.阿尔茨海默病中线粒体功能障碍的机制:新的治疗希望。
Oxid Med Cell Longev. 2022 May 14;2022:4759963. doi: 10.1155/2022/4759963. eCollection 2022.
2
Brains for Dementia Research: The Importance of Cohorts in Brain Banking.用于痴呆症研究的大脑:大脑库中队列的重要性。
Neurosci Bull. 2019 Apr;35(2):289-294. doi: 10.1007/s12264-018-0327-2. Epub 2019 Jan 2.
3
Pharmacological enhancement of memory or cognition in normal subjects.正常受试者记忆或认知的药理学增强。
Front Syst Neurosci. 2014 May 20;8:90. doi: 10.3389/fnsys.2014.00090. eCollection 2014.
4
In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease.花青素通过调控 FKBP52 预防阿尔茨海默病的计算研究。
Evid Based Complement Alternat Med. 2014;2014:450592. doi: 10.1155/2014/450592. Epub 2014 May 12.
5
RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.对阿尔茨海默病相关基因进行RNA沉默可增强线粒体功能和突触活性。
Biochim Biophys Acta. 2013 Dec;1832(12):2368-78. doi: 10.1016/j.bbadis.2013.09.008. Epub 2013 Sep 21.
6
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage.淀粉样β蛋白诱导糖原合酶激酶3β磷酸化阿尔茨海默病中的电压依赖性阴离子通道1:对突触功能障碍和神经元损伤的影响
Biochim Biophys Acta. 2013 Dec;1832(12):1913-21. doi: 10.1016/j.bbadis.2013.06.012. Epub 2013 Jun 28.
7
Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.衰老和阿尔茨海默病中的线粒体氧化损伤:对线粒体靶向抗氧化疗法的启示。
J Biomed Biotechnol. 2006;2006(3):31372. doi: 10.1155/JBB/2006/31372.